Literature DB >> 19484352

MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis.

Vladimir Vasku1, Julie Bienertova-Vasku, Miroslav Necas, Anna Vasku.   

Abstract

The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (P(g) = 0.03) and allelic frequency (P(a) = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12-2.15, P = 0.004814, P(corr) = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (P(a) = 0.02) and in those with a frequent tonsillitis/tonsillectomy (P(a) = 0.04). No difference was observed between patients with and without positive family history of psoriasis (P(a) = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33-7.56, P(corr) = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484352     DOI: 10.1007/s10238-009-0054-0

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  19 in total

1.  Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism.

Authors:  Fabiola Festa; Rajiv Kumar; Somali Sanyal; Birgitte Undén; Linda Nordfors; Bengt Lindholm; Erna Snellman; Martin Schalling; Asta Försti; Kari Hemminki
Journal:  Mutat Res       Date:  2005-03-26       Impact factor: 2.433

2.  The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis.

Authors:  K Zhang; R Zhang; X Li; G Yin; X Niu; R Hou
Journal:  Clin Exp Dermatol       Date:  2007-05-17       Impact factor: 3.470

3.  Polymorphisms in the MTHFR and VDR genes and skin cancer risk.

Authors:  Jiali Han; Graham A Colditz; David J Hunter
Journal:  Carcinogenesis       Date:  2006-08-31       Impact factor: 4.944

4.  Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.

Authors:  M Malerba; P Gisondi; A Radaeli; R Sala; P G Calzavara Pinton; G Girolomoni
Journal:  Br J Dermatol       Date:  2006-12       Impact factor: 9.302

5.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

6.  Update on nutrition and psoriasis.

Authors:  J H Prystowsky; A Orologa; S Taylor
Journal:  Int J Dermatol       Date:  1993-08       Impact factor: 2.736

7.  The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis.

Authors:  John B Mee; Claire M Johnson; Nilesh Morar; Frank Burslem; Richard W Groves
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.

Authors:  Birgül Vanizor Kural; Asim Orem; Gülseren Cimşit; Hüseyin Avni Uydu; Yunus Emre Yandi; Ahmet Alver
Journal:  Clin Chim Acta       Date:  2003-06       Impact factor: 3.786

Review 9.  Folic acid in general medicine and dermatology.

Authors:  Paolo Gisondi; Francesca Fantuzzi; Mario Malerba; Giampiero Girolomoni
Journal:  J Dermatolog Treat       Date:  2007       Impact factor: 3.359

10.  Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma.

Authors:  Zhenzhong Zhang; Wei Liu; Xin Jia; Yan Gao; Kari Hemminki; Bengt Lindholm
Journal:  Clin Chim Acta       Date:  2004-04       Impact factor: 3.786

View more
  9 in total

1.  Methylenetetrahydrofolate reductase (MTHFR) 677C>T gene polymorphism as a possible factor for reducing clinical severity of psoriasis.

Authors:  Ercan Karabacak; Ersin Aydin; Omer Ozcan; Bilal Dogan; Mustafa Gultepe; Alpaslan Cosar; Tuba Muftuoglu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymorphism and gene expression).

Authors:  Ahmad A Al Robaee
Journal:  Int J Health Sci (Qassim)       Date:  2010-11

3.  Opposite impact of Methylene tetrahydrofolate reductase C677T and Methylene tetrahydrofolate reductase A1298C gene polymorphisms on systemic inflammation.

Authors:  Koroush Khalighi; Gang Cheng; Seyedabbas Mirabbasi; Bahar Khalighi; Yin Wu; Wuqiang Fan
Journal:  J Clin Lab Anal       Date:  2018-02-03       Impact factor: 2.352

4.  Interaction of MTHFR gene with smoking and alcohol use and haplotype combination susceptibility to psoriasis in Chinese population.

Authors:  Quan Luo; Jingxin Zeng; Wei Li; Ling Lin; Xin Zhou; Xin Tian; Weiyu Liu; Lidan Zhang; Xibao Zhang
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

5.  Association of methylentetraydrofolate reductase (MTHFR) 677 C > T gene polymorphism and homocysteine levels in psoriasis vulgaris patients from Malaysia: a case-control study.

Authors:  Siaw C Liew; Esha Das-Gupta; Shew F Wong; Nagarajah Lee; Najeeb Safdar; Adawiyah Jamil
Journal:  Nutr J       Date:  2012-01-05       Impact factor: 3.271

6.  MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis.

Authors:  Jie Zhu; Zhicheng Wang; Lu Tao; Ling Han; Qiong Huang; Xu Fang; Ke Yang; Guiqin Huang; Zhizhong Zheng; Nikhil Yawalkar; Zhenghua Zhang; Kexiang Yan
Journal:  Front Med (Lausanne)       Date:  2022-04-11

Review 7.  Homocysteine: A Potential Common Route for Cardiovascular Risk and DNA Methylation in Psoriasis.

Authors:  Wen-Ming Wang; Hong-Zhong Jin
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

Review 8.  Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks.

Authors:  Shanel Raghubeer; Tandi E Matsha
Journal:  Nutrients       Date:  2021-12-20       Impact factor: 5.717

9.  Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in psoriasis in southern Turkey.

Authors:  Muzeyyen Izmirli; Bilge Bulbul Sen; Eminenur Rifaioglu; Bulent Gogebakan; Ozgur Aldemir; Tuba Sen; Ozlem Ekiz; Davut Alptekin
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.